Home   ->   news   ->   Press Releases

Press Releases

WuXi PharmaTech Listed among Asia's Fastest Growing Companies, Third Year Running

December 14, 2006 – Shanghai, China – WuXi PharmaTech, China's leading provider of pharmaceutical R&D outsourcing services announced today that it has been named 173rd on the Deloitte Fast 500 Asian. This is the third consecutive year the pharmaceutical service company has received the prestigious award, placing it in an elite group of only 58 companies.

The Deloitte Touche Tohmatsu (Deloitte) Technology Fast 500 Asia Pacific award is Asia's most objective industry-ranking standard, focusing specifically on the technology sector. The award was first introduced in 2001 to recognize the most exceptional of Asia's 500 fastest-growing technology companies from industries including all areas of technology, ranging form internet based companies to biotechnology. The 2006 list, like years prior, is a mixture of both public and private companies.

This year's 173rd ranking represents a 244% 3-year annual growth rate for the pharmaceutical service company. WuXi PharmaTech is among only 58 companies to be recognized for a third consecutive year.

"We are honored to have our success once again recognized," commented Dr. Ge Li, Chairman and CEO of WuXi PharmaTech. "It is a great encouragement and satisfaction to be listed alongside prominent companies such as Infosys of India and others who have been selected for a third consecutive year. This designation reflects highly on WuXi PharmaTech's commitment to quality of service, high operating standards, and transparency," continued Dr. Li.

About WuXi PharmaTech (Cayman) Inc. WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.

back to top